Page last updated: 2024-11-05

paracymethadol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

paracymethadol: nor-LAAM refers to (S-(R*,R*))-(-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15129
CHEMBL ID2111032
CHEBI ID176690
SCHEMBL ID489170
MeSH IDM0074893

Synonyms (41)

Synonym
CHEBI:176690
1477-39-0
[6-(methylamino)-4,4-diphenylheptan-3-yl] acetate
benzeneethanol, .alpha.-ethyl-.beta.-[2-(methylamino)propyl]-.beta.-phenyl-, acetate (ester)
noracymethadol
noracymethadolum [inn-latin]
noracetylmethadol
einecs 216-027-8
noracimetadol [inn-spanish]
paracymethadol
noracimetadolo [dcit]
alpha-ethyl-beta-(2-(methylamino)propyl)-beta-phenylbenzeneethanol, acetate (ester)
noracymethadol [inn:ban]
dea no. 9633
noracimetadol
unii-ku5u13xy7j
noracymethadolum
ku5u13xy7j ,
noracimetadolo
noracymethadol [mi]
ids-nn-004
noracymethadol [inn]
(+/-)-.alpha.-3-acetoxy-6-methylamino-4,4-diphenylheptane
noracetylmethadone
dl-6-methylamino-4,4-diphenyl-3-heptanol acetate
acetylnormethadol
6-(methylamino)-4,4-diphenyl-3-heptanol acetate (ester)
benzeneethanol, .alpha.-ethyl-.beta.-(2-(methylamino)propyl)-.beta.-phenyl-, acetate (ester)
normethadyl acetate
VWCUGCYZZGRKEE-UHFFFAOYSA-N
3-heptanol, 6-(methylamino)-4,4-diphenyl-, acetate (ester)
3-heptanol, 6-(methylamino)-4,4-diphenyl-, acetate
1-ethyl-4-(methylamino)-2,2-diphenylpentyl acetate #
benzeneethanol, .alpha.-ethyl-.beta.-[2-(methylamino)propyl]-.beta.-phenyl-, acetate
SCHEMBL489170
CHEMBL2111032
CS-7391
HY-U00349
Q13218264
6-(methylamino)-4,4-diphenylheptan-3-yl acetate
DTXSID30860679

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" These LAAM-induced changes demonstrated dose- and time-dependence within that dosage range producing mortality."( L-alpha-acetylmethadol-induced tissue alterations in mice.
Freeman, RW; Harbison, RD; James, RC, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Levomethadyl Acetate Metabolism Pathway18

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (37.50)18.7374
1990's5 (20.83)18.2507
2000's9 (37.50)29.6817
2010's1 (4.17)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.86 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.57%)5.53%
Reviews1 (3.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]